Menu

Dozens of Researchers Exposed to Anthrax

As many as 75 scientists at the US Centers for Disease Control and Prevention may have come in contact with live Bacillus anthracis, the bacteria that cause anthrax.

Jun 22, 2014
Bob Grant

Color-enhanced scanning electron micrograph shows rod-shaped Bacillus anthracis (yellow) and a red blood cell (red) in a monkey’s spleen.NIAID, ARTHUR FRIEDLANDERApproximately 75 researchers working at the US Centers for Disease Control and Prevention (CDC) in Atlanta may have been exposed to live anthrax bacteria when the microbes were sent to laboratories that were not equipped to safely handle the pathogen, the federal agency announced Thursday (June 19).

CDC scientists were studying the bacteria in a high-level biosecurity lab and then transferred the samples to three lower-security labs without first properly inactivating the live microbes. Workers in those labs handled the samples without using personal protective equipment, such as gloves. The procedural lapse happened between June 6 and June 13, and CDC spokesperson Thomas Skinner told The New York Times that while none of the researchers exposed to the bacteria are showing symptoms of infection, many of them are receiving prophylactic antibiotic treatment “out of an abundance of caution.”

CNN reported on Thursday afternoon that 54 CDC employees determined to have been in the labs or hallways at the time live anthrax was present have been seen by the agency’s Occupational Health Clinic. Of those, only two people chose not to take oral antibiotics. An additional 27 staffers have been given the anthrax vaccine. Other exposed individuals were scheduled to be seen by doctors on Friday.

Paul Meechan, director of the environmental health and safety compliance office at the CDC, told The Guardian that the agency discovered the exposure on the evening of June 13 and is conducting an internal investigation to determine how the lapse occurred. “This should not have happened,” he said. “We’re taking care of it. We will not let our people be at risk.”

“We will report findings of this review and all steps we take to improve lab-safety processes as a result of this incident,” the CDC’s statement read.

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Application of TruBIOME™ to Increase Mouse Model Reproducibility
Application of TruBIOME™ to Increase Mouse Model Reproducibility
With this application note from Taconic, learn about the effects of the microbiome on reproducibility and predictability and how TruBIOME™ helps researchers generate custom microbiota mouse models!
Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.